Douglas J. M. Allen
26Patents
9h-index
58Co-inventors
74Inventor score
Filing activity: Apr 20, 1989 → May 6, 2004
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5322063A | Hydrophilic polyurethane membranes for electrochemical glucose sensors | Emerging Cross-Sectional Technologies | 1,366 | Expired |
| US5284140A | Acrylic copolymer membranes for biosensors | Chemistry; Metallurgy | 647 | Expired |
| US5476094A | Acrylic copolymer membranes for biosensors | Chemistry; Metallurgy | 178 | Expired |
| US5312925A | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dih ydro-2H-indol-2-one-hydrochloride | Human Necessities | 68 | Expired |
| US5248699A | Sertraline polymorph | Chemistry; Metallurgy | 45 | Expired |
| US6268489A | Azithromycin dihydrate | Chemistry; Metallurgy | 37 | Expired |
| US6239141A | Trovafloxacin oral suspensions | Human Necessities | 19 | Expired |
| US5036099A | Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide | Human Necessities | 11 | Expired |
| US6262067A | Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions | Human Necessities | 10 | Expired |
| US6617321B2 | 2-methyl-thieno-benzodiazepine formulation | Human Necessities | 5 | Expired |
| US5760009A | Spirostanyl glycosidal crystalline monohydrate | Human Necessities | 5 | Expired |
| US7303764B2 | 2-methyl-thieno-benzodiazepine formulation | Human Necessities | 4 | Expired |
| US6706721B1 | N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate | Chemistry; Metallurgy | 4 | Expired |
| US5804562A | Spirostanyl glycosidal crystals | Human Necessities | 2 | Expired |
| US6436987B1 | Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid | Human Necessities | 2 | Expired |
| US6465437B1 | Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7521456B2 | N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate | Chemistry; Metallurgy | 1 | Expired |
| US6262272A | Method of synthesis of pyrrole amides | Chemistry; Metallurgy | 1 | Expired |
| US4997949A | Crystalline 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl) thiazole dihydrochloride trihydrate | Chemistry; Metallurgy | 1 | Expired |
| US6583274B1 | Crystalline forms of macrolide antibiotic | Chemistry; Metallurgy | 1 | Expired |
| US6861412B2 | Diphosphate salt of A 4″-substituted-9-deoxo-9A-AZA-9A-homoerythromycin derivative and its pharmaceutical composition | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6194585A | Process for preparing 5-lipoxygenase inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US6080756A | Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin | Human Necessities | 0 | Expired |
| US5914329A | Dimesylate salts of neuropeptide Y ligands | Human Necessities | 0 | Expired |
| US6683106B2 | N-(indole-2-carbonyl)-b-alaninamide crystal forms | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.